Tech Company Financing Transactions
Boomerang Medical Funding Round
On 9/4/2025, Boomerang Medical secured $20 million in Series B financing from Arboretum Ventures, Hatteras Venture Partners and private investors.
Transaction Overview
Company Name
Announced On
9/4/2025
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Series B
Investors
Arboretum Ventures (Lead Investor)
Hatteras Venture Partners (Lead Investor)
Proceeds Purpose
The company intends to use the funds to advance BOOM-IBD2, the first pivotal trial of implantable neuromodulation in inflammatory bowel disease, with an initial focus on ulcerative colitis.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2495 Hospital Dr. 300
Mountain View, CA 94040
USA
Mountain View, CA 94040
USA
Phone
Website
Email Address
Overview
Boomerang Medical is a women-led clinical-stage company headquartered on the campus of El Camino Hospital in Mountain View, California. We are united by a common mission to bring new treatment options to patients with complex diseases. We are conducting clinical trials on a device-focused approach for treating autoimmune diseases by harnessing the body's own physiology through bioelectronic medicine.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Heather Simonsen
Chief Medical Officer
Amy Lightner
Chief Operating Officer
Pharoah Garma
VP - Finance
Mariela Baughman
Browse more venture capital transactions:
Prev: 9/4/2025: Enveda venture capital transaction
Next: 9/4/2025: MagicDoor venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to record every notable VC transaction. VC investment data records reported here come from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs